Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release

Benzer Materyaller

• Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release
  Yazar:: Karlowsky, James A., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Longitudinal Assessment of Antipneumococcal Susceptibility in the United States
  Yazar:: Jones, Mark E., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States
  Yazar:: Karlowsky, James A., ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV
  Yazar:: Jones, Mark E., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
  Yazar:: Wenzel, Richard P., ve diğerleri
  Baskı/Yayın Bilgisi: (2003)